BRAF and thyroid gland follicular carcinoma: In our recent study, we found no statistical significance in the prevalence of BRAF V600E, RET/PTC rearrangements or RAS mutations in papillary and follicular thyroid carcinomas from an iodine-rich country (Japan) and an iodine-deficient country (Vietnam) [20].